Research output per year
Research output per year
Personal profile
Research Biography
Welcome to my home page. I am a Research Fellow in the Precision Medicine Group at the College of Medicine and Public Health, Flinders University.
My research interest is in using innovative modelling and simulation approaches to aid optimal drug development, precision drug use, and regulatory decisions. I use newly available clinical trial data to develop clinical prediction tools or applications that provide personalised likelihoods of expected therapeutic and adverse outcomes to contemporary rheumatoid arthritis and cancer medicines. Such tools allow informed treatment decisions to be made based on patient’s characteristics which may be predictive of efficacy or toxicity.
Our research group is always interested in identifying and working with PhD and Honours students, and have several projects available. Students would need to obtain a scholarship that will cover their own living expenses and tuition fees, but we are more than happy to support qualified students in applying for available funding. Please contact me if you are interested.
Education/Academic qualification
PhD, University of South Australia
15 Feb 2014 → 19 Jun 2017
Award Date: 19 Jun 2017
Master of Science, University of Iowa
10 Aug 2009 → 16 Dec 2011
Award Date: 16 Dec 2011
Bachelor of Science, University of Jordan
1 Sep 2004 → 15 Jun 2009
Award Date: 15 Jun 2009
Fingerprint
Dive into the research topics where Ahmad Abuhelwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis
Abuhelwa, A. Y., Foster, D. J. R., Manning-Bennett, A., Sorich, M. J., Proudman, S., Wiese, M. D. & Hopkins, A. M., 1 Jan 2021, In: Therapeutic Advances in Musculoskeletal Disease. 13, p. 1-7 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
Modi, N. D., Tan, J. Q. E., Rowland, A., Koczwara, B., Abuhelwa, A. Y., Kichenadasse, G., McKinnon, R. A., Wiese, M. D., Sorich, M. J. & Hopkins, A. M., 22 Mar 2021, In: npj Breast Cancer. 7, 1, 6 p., 30.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Value of the lung immune prognostic index in patients with non‐small cell lung cancer initiating first‐line atezolizumab combination therapy: Subgroup analysis of the impower150 trial
Hopkins, A. M., Kichenadasse, G., Abuhelwa, A. Y., McKinnon, R. A., Rowland, A. & Sorich, M. J., 9 Mar 2021, In: Cancers. 13, 5, 9 p., 1176.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants
Meola, T. R., Abuhelwa, A. Y., Joyce, P., Clifton, P. & Prestidge, C. A., 11 Sep 2020, (E-pub ahead of print) In: Drug Delivery and Translational Research. 12 p.Research output: Contribution to journal › Article › peer-review
-
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
Wiese, M. D., Manning-Bennett, A. T. & Abuhelwa, A. Y., 3 May 2020, In: Expert Opinion On Investigational Drugs. 29, 5, p. 475-482 8 p.Research output: Contribution to journal › Review article › peer-review